newsPatents for NLRP3 inflammasome-inhibiting compounds granted in US and Europe23 January 2020 | By Hannah Balfour (European Pharmaceutical Review)Inflazome has announced that the US and EU will grant patents to their NLRP3 inflammasome inhibiting compounds.